2025-01-26 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**1. Performance Comparison and Divergence:**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of health benefits and services.

The cumulative return of UNH (145.62%) significantly outperforms the S&P 500 (VOO) cumulative return (52.12%).  The difference is 93.5%, placing it at the 25.6th percentile of the historical range of divergence (min: 62.5%, max: 183.7%).  This suggests UNH's outperformance is relatively moderate compared to its historical highs.

The Alpha and Beta analysis shows inconsistent performance over different periods:

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2020-2022  | 92.0% | 5.5% | 94.0% | 1.0 | 473.3 |
| 2021-2023  | 60.0% | 5.5% | 51.0% | 1.0 | 477.0 |
| 2022-2024  | -24.0% | 16.6% | -47.0% | 1.0 | 465.5 |
| 2023-2025  | -9.0% | 16.6% | -52.0% | 1.0 | 490.1 |

Noteworthy is the negative CAGR in the last two years, indicating a period of underperformance.  The high Alpha values suggest outperformance relative to the market, but consistency is lacking.


**2. Recent Price Movement:**

* **Closing Price:** $532.51
* **5-Day Moving Average:** $523.35
* **20-Day Moving Average:** $519.36
* **60-Day Moving Average:** $552.21

The price is currently above its 5 and 20-day moving averages, suggesting short-term upward momentum, but below the 60-day moving average, indicating a potential near-term resistance level.  The recent price change ($0.52 increase) is relatively small and not indicative of a significant surge or drop.


**3. Technical Indicators and Expected Return:**

* **RSI:** 62.26 – Suggests the stock is neither overbought nor oversold, in a neutral territory.
* **PPO:** 0.5984 – A positive PPO suggests upward momentum, but the value is relatively low.
* **Recent Relative Strength Change (20-day):** +5.1% – Indicates short-term upward momentum.
* **Expected Return (2+ years):** 368.5% – This represents a significant expected outperformance compared to the S&P 500 over the long term.  This projection should be treated with caution as future performance is not guaranteed.


**4. Recent Earnings Analysis:**

The earnings data shows some volatility:

| Date       | EPS    | Revenue       |
|------------|--------|---------------|
| 2024-11-04 | 6.56   | $100.82 B     |
| 2024-08-09 | 4.58   | $98.86 B     |
| 2024-05-09 | -1.53  | $99.80 B     |
| 2023-11-06 | 6.31   | $92.36 B     |
| 2024-11-04 | 6.31   | $92.36 B     | *(Duplicate entry, likely an error)*


Note the significant drop in EPS in the May 2024 quarter.  Revenue remains relatively stable, suggesting potential issues with profitability or cost control during that period.  Further investigation is required to understand the cause of the EPS decline.  The duplicate entry on November 4th, 2024 requires clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue     | Profit Margin |
|---------|-------------|---------------|
| 2024-09-30 | $99.18B    | 21.56%        |
| 2024-06-30 | $97.86B    | 21.52%        |
| 2024-03-31 | $98.78B    | 22.26%        |
| 2023-12-31 | $93.25B    | 22.33%        |
| 2023-09-30 | $91.36B    | 24.51%        |

Revenue shows a general upward trend, although there is some fluctuation. Profit margins have been relatively stable, with a slight dip in recent quarters.

**Capital and Profitability:**

| Quarter | Equity      | ROE           |
|---------|-------------|---------------|
| 2024-09-30 | $94.53B    | 6.41%         |
| 2024-06-30 | $89.36B    | 4.72%         |
| 2024-03-31 | $86.69B    | -1.63%        |
| 2023-12-31 | $88.76B    | 6.15%         |
| 2023-09-30 | $84.49B    | 6.91%         |

Equity shows growth, however, ROE exhibits some volatility, mirroring the concerns raised by the EPS data. The negative ROE in Q1 2024 is particularly concerning.


**7. Overall Analysis:**

UNH has demonstrated strong historical outperformance compared to the S&P 500. However, recent performance (past two years) has been less impressive.  While the current price shows some short-term upward momentum,  the negative EPS in Q1 2024 and the declining ROE raise concerns about profitability and potential headwinds.  The long-term outlook (368.5% projected return) is ambitious and requires further due diligence.  The significant volatility in both earnings and ROE necessitates a thorough analysis of the underlying factors before making any investment decisions.  The data suggests a need to monitor UNH's performance closely, especially regarding profitability and cost management.  Long-term investors should carefully consider the risks associated with the recent performance downturn before investing.
